Universal Technical Institute, Inc. (UTI)
NYSEConsumer StaplesEducation & Training ServicesSnapshot 2026-09-14
$20.33+0.10%
Close 2026-09-14 · 1-day change
NYSEConsumer StaplesEducation & Training ServicesSnapshot 2026-09-14
Research Workspace
Put UTI beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Staples is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Revenue between $905 million and $915 million for fiscal 2026: FY26 rev guide $896.5M vs $905M target.
View ThesisRevenue growth is slowing — up about 9% over the past year and decelerating.
View GrowthMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 60% in its worst 12-month stretch.
View RiskUTI's growth has to keep compounding to justify the price. Revenue guidance aligns with growth objectives, but recent performance sits below its industry cohort. Revenue for fiscal 2026 is guided between $896.5 million and $915 million, missing the $905 million target. UTI trades at 33× P/E versus a peer median of 16×. The price reflects less growth than forecast, indicating modest expectations. If UTI cuts guidance on the next call, that could negatively impact the stock. Peer multiples imply a price about 17% above where it trades. This read is provisional.
Trailing returns as of 2026-09-14. UTI is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 6 analysts currently covering UTI (as of Sep 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare UTI with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| UTI Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Education Services — fair value, gap to price, and forward P/E.
Compare the value case
Put UTI next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Reaffirm and update fiscal 2026 financial guidance
Enrollment headwinds impact fiscal 2026 financial guidance.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Execute North Star strategy focusing on growth and optimization
Near-term headwinds could hinder growth strategy execution.
Advances: Reaffirm and update fiscal 2026 financial guidance
Revenue guidance aligns with growth objectives and staffing increase.
Advances: Reaffirm full-year revenue guidance
Earnings call provides clarity on revenue guidance.
Advances: Increase new student starts
Strong demand supports increasing new student starts objective.
Advances: Increase new student starts
Increased demand directly supports new student starts objective.
Threatens: Reaffirm full-year revenue guidance
Earnings lag indicates potential issues with revenue guidance.
